We are live on ! Find out more
PM

Prosight Management Portfolio holdings

AUM $580M
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
+0.56%
1 Year Est. Return
+29.81%
3 Year Est. Return
+39.55%
5 Year Est. Return
-6.93%
10 Year Est. Return
–
AUM
$136M
AUM Growth
–
Cap. Flow
+$136M
Cap. Flow %
99.9%
Top 10 Hldgs %
63.64%
Holding
29
New
29
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$17.6M
2
CDTX
Cidara Therapeutics
CDTX
+$12.5M
3
MGNX icon
MacroGenics
MGNX
+$11.3M
4
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$8.08M
5
SBRA icon
Sabra Healthcare REIT
SBRA
+$8M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 89.55%
2 Real Estate 5.55%
3 Consumer Discretionary 3.69%
4 Miscellaneous 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGN
1
DELISTED
Allergan plc
AGN
$16M 11.79%
+98,000
New +$17.6M
MGNX icon
2
MacroGenics
MGNX
$263M
$11.5M 8.49%
+607,696
New +$11.3M
CDTX
3
DELISTED
Cidara Therapeutics
CDTX
$11.2M 8.24%
+82,394
New +$12.5M
EIGR
4
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$9.47M 6.96%
+22,626
New +$8.08M
SBRA icon
5
Sabra Healthcare REIT
SBRA
$5.27B
$7.55M 5.55%
+402,057
New +$8M
CNC icon
6
Centene
CNC
$32B
$7.16M 5.27%
+142,000
New +$6.88M
CMRX
7
DELISTED
Chimerix, Inc.
CMRX
$6.85M 5.04%
+1,478,519
New +$7.03M
AKAO
8
DELISTED
Achaogen Inc
AKAO
$6.13M 4.51%
+570,920
New +$7.17M
QURE icon
9
uniQure
QURE
$3.38B
$5.58M 4.1%
+284,717
New +$4.33M
AFAM
10
DELISTED
Almost Family Inc
AFAM
$5.01M 3.69%
+90,548
New +$4.82M
RETA
11
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$4.9M 3.6%
+172,897
New +$4.82M
QTNT
12
DELISTED
Quotient Limited Ordinary Shares
QTNT
$4.62M 3.39%
+23,313
New +$4.48M
RXDX
13
DELISTED
Ignyta, Inc.
RXDX
$4.58M 3.36%
+171,352
New +$2.78M
IOVA icon
14
Iovance Biotherapeutics
IOVA
$3.63B
$4.05M 2.98%
+506,852
New +$4.07M
ELGX
15
DELISTED
Endologix Inc
ELGX
$3.51M 2.58%
+65,582
New +$3.46M
RDUS
16
DELISTED
Radius Health, Inc.
RDUS
$3.5M 2.57%
+110,000
New +$3.45M
PRTK
17
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$3.19M 2.35%
+178,453
New +$3.72M
AVEO
18
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$2.95M 2.17%
+105,769
New +$3.28M
NBRV
19
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$2.94M 2.16%
+1,966
New +$3.11M
CLVS
20
DELISTED
Clovis Oncology, Inc.
CLVS
$2.72M 2%
+40,000
New +$2.8M
BLCM
21
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$2.53M 1.86%
+30,135
New +$2.96M
RARE icon
22
Ultragenyx Pharmaceutical
RARE
$2.52B
$2.07M 1.52%
+44,600
New +$2.19M
DXCM icon
23
DexCom
DXCM
$34.3B
$1.79M 1.32%
+124,792
New +$1.62M
EFOR
24
PUT
Everforth Inc
EFOR
$1.31B
$1.65M 1.22%
+25,700
New +$1.56M
LPCN icon
25
Lipocine
LPCN
$17.9M
$1.28M 0.94%
+21,947
New +$1.36M
1
2

Similar funds

SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
CCWM
Correct Capital Wealth Management Clayton, Missouri $580M AUM 16.45% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return
RIS
Retirement Income Solutions Ann Arbor, Michigan $581M AUM 19.42% 1-Year Est. Return
MFS
McNamara Financial Services Marshfield, Massachusetts $580M AUM 17.89% 1-Year Est. Return
GFI
Global Frontier Investments Charleston, South Carolina $581M AUM 8.55% 1-Year Est. Return
PWM
Praetorian Wealth Management Carmel, California $580M AUM 19.43% 1-Year Est. Return
CA
COFG Advisors Oak Brook, Illinois $579M AUM

Prosight Management's Q4 2017 Portfolio in Review

Q4 2017 is the first quarter with a 13F filing on record for Prosight Management, which disclosed 29 positions worth $136M. Its ten largest holdings account for 64% of the portfolio.

Its largest position is Allergan plc: 98,000 shares worth $16M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, followed by Real Estate and Consumer Discretionary.

  • Prosight Management's largest Q4 2017 buy was Allergan plc: 98,000 shares worth $16M.
  • Prosight Management's ten largest holdings make up 64% of its $136M portfolio in Q4 2017.
  • Prosight Management disclosed 29 positions in Q4 2017, its first 13F filing on record.

Based on Prosight Management's 13F filing for Q4 2017, filed 13 Feb 2018.